Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis
Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early r...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:47b0c407d9c94d2297294d7b6b882c0d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:47b0c407d9c94d2297294d7b6b882c0d2021-11-30T04:16:09ZEfficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis2214-751910.1016/j.inat.2021.101425https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d2022-03-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214751921003376https://doaj.org/toc/2214-7519Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early reocclusion during MT for ELVO due to ICAS. They were divided into the following 3 groups according to rescue treatment methods: 1) Combined intravenous (IV) + intra-arterial (IA) tirofiban group (n = 48), emergent percutaneous transluminal angioplasty (PTA) and intracranial stenting (ICS) followed by IA injection of tirofiban and a continuous IV tirofiban infusion for 8 h; 2) IA tirofiban group (n = 33), only IA 0.5–1.0 mg tirofiban infusion for 5 min regardless of PTA or ICS; and 3) no tirofiban group (n = 36), no tirofiban injection regardless of PTA or ICS. Results: ICS was more frequently performed in the combined IV + IA tirofiban group than in the IA tirofiban group (100% vs 46%, p < 0.05). The proportion of m-TICI grades 2b and 3 (93.8% vs. 63.6%, p < 0.05), especially the proportion of m-TICI grade 3 (81.3% vs. 36.4%, p < 0.05), was higher in the combined IV + IA tirofiban group than in the IA tirofiban group. The rate of postoperative intracranial hemorrhage was not significantly different among the three groups. The rate of modified Rankin scale scores of 0–2 at 3 months after MT was highest in the combined IV + IA tirofiban group (63%), followed by the IA tirofiban (46%) and no tirofiban groups (8%, p < 0.05). Conclusion: ICS with IA and continuous IV tirofiban injections for 8 h is an effective and safe protocol for failed MT in patients with ELVO with ICAS.Yun Ho NohJi Young LeeSeok Mann YoonYu Jin HaJaewoo ChungJung Ho KoDong Seong ShinJae-Min AhnHyuk Jin OhJai-Joon ShimMan Ryul LeeJae Sang OhElsevierarticleIschemic strokeIntracranial arteriosclerosisThrombectomyThrombosisTirofibanSurgeryRD1-811Neurology. Diseases of the nervous systemRC346-429ENInterdisciplinary Neurosurgery, Vol 27, Iss , Pp 101425- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ischemic stroke Intracranial arteriosclerosis Thrombectomy Thrombosis Tirofiban Surgery RD1-811 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Ischemic stroke Intracranial arteriosclerosis Thrombectomy Thrombosis Tirofiban Surgery RD1-811 Neurology. Diseases of the nervous system RC346-429 Yun Ho Noh Ji Young Lee Seok Mann Yoon Yu Jin Ha Jaewoo Chung Jung Ho Ko Dong Seong Shin Jae-Min Ahn Hyuk Jin Oh Jai-Joon Shim Man Ryul Lee Jae Sang Oh Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
description |
Objective: We aimed to develop an optimal protocol for failed mechanical thrombectomy (MT) in cases of emergent large vessel occlusion (ELVO) with intracranial atherosclerosis (ICAS). Methods: A total of 117 patients without underlying heart disease who were not taking antiplatelet drugs had early reocclusion during MT for ELVO due to ICAS. They were divided into the following 3 groups according to rescue treatment methods: 1) Combined intravenous (IV) + intra-arterial (IA) tirofiban group (n = 48), emergent percutaneous transluminal angioplasty (PTA) and intracranial stenting (ICS) followed by IA injection of tirofiban and a continuous IV tirofiban infusion for 8 h; 2) IA tirofiban group (n = 33), only IA 0.5–1.0 mg tirofiban infusion for 5 min regardless of PTA or ICS; and 3) no tirofiban group (n = 36), no tirofiban injection regardless of PTA or ICS. Results: ICS was more frequently performed in the combined IV + IA tirofiban group than in the IA tirofiban group (100% vs 46%, p < 0.05). The proportion of m-TICI grades 2b and 3 (93.8% vs. 63.6%, p < 0.05), especially the proportion of m-TICI grade 3 (81.3% vs. 36.4%, p < 0.05), was higher in the combined IV + IA tirofiban group than in the IA tirofiban group. The rate of postoperative intracranial hemorrhage was not significantly different among the three groups. The rate of modified Rankin scale scores of 0–2 at 3 months after MT was highest in the combined IV + IA tirofiban group (63%), followed by the IA tirofiban (46%) and no tirofiban groups (8%, p < 0.05). Conclusion: ICS with IA and continuous IV tirofiban injections for 8 h is an effective and safe protocol for failed MT in patients with ELVO with ICAS. |
format |
article |
author |
Yun Ho Noh Ji Young Lee Seok Mann Yoon Yu Jin Ha Jaewoo Chung Jung Ho Ko Dong Seong Shin Jae-Min Ahn Hyuk Jin Oh Jai-Joon Shim Man Ryul Lee Jae Sang Oh |
author_facet |
Yun Ho Noh Ji Young Lee Seok Mann Yoon Yu Jin Ha Jaewoo Chung Jung Ho Ko Dong Seong Shin Jae-Min Ahn Hyuk Jin Oh Jai-Joon Shim Man Ryul Lee Jae Sang Oh |
author_sort |
Yun Ho Noh |
title |
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
title_short |
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
title_full |
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
title_fullStr |
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
title_full_unstemmed |
Efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
title_sort |
efficacy and safety of tirofiban injection with intracranial stenting in early reocclusion due to intracranial atherosclerosis |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/47b0c407d9c94d2297294d7b6b882c0d |
work_keys_str_mv |
AT yunhonoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT jiyounglee efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT seokmannyoon efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT yujinha efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT jaewoochung efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT junghoko efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT dongseongshin efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT jaeminahn efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT hyukjinoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT jaijoonshim efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT manryullee efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis AT jaesangoh efficacyandsafetyoftirofibaninjectionwithintracranialstentinginearlyreocclusionduetointracranialatherosclerosis |
_version_ |
1718406799147663360 |